Considerations for Choosing Soluble Immune Markers to Determine Safety of Novel Vaginal Products

Several soluble cytokines have been associated with microbicide-induced cervicovaginal inflammation, non-optimal vaginal microbiota, and risk of HIV acquisition. Many of these biomarkers are used in preclinical assays to estimate the safety of vaginally applied products. However, there are currently...

Descripción completa

Detalles Bibliográficos
Autores principales: Happel, Anna-Ursula, Sivro, Aida, Liebenberg, Lenine, Passmore, Jo Ann, Mitchell, Caroline M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Reproductive Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580790/
https://www.ncbi.nlm.nih.gov/pubmed/36303630
http://dx.doi.org/10.3389/frph.2022.899277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580790/
https://www.ncbi.nlm.nih.gov/pubmed/36303630
http://dx.doi.org/10.3389/frph.2022.899277

Ejemplares similares